Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201

被引：0

作者：

Ciombor, K. K. ^{[1
]}

Hong, S. ^{[2
]}

Eng, C. ^{[3
]}

Yao, X. ^{[4
]}

You, N. ^{[5
]}

Das, P. ^{[6
]}

Chakravarthy, A. ^{[7
]}

O'Dwyer, P. J. ^{[8
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Internal Med Hematol Oncol Dept, Preston Canc Res Bldg, Nashville, TN USA

[2] Dana Farber Canc Inst, Data Sci, Boston, MA USA

[3] Vanderbilt Ingram Canc Ctr, Hematol Oncol Dept, Nashville, TN USA

[4] Cleveland Clin Florida, Oncol, Weston, FL USA

[5] Univ Texas MD Anderson Canc Ctr, Colorectal Surg, Houston, TX USA

[6] Univ Texas MD Anderson Canc Ctr, Radiol Oncol, Houston, TX USA

[7] Vanderbilt Univ, Med Ctr, Radiat Oncol, Nashville, TN USA

[8] ECOG ACRIN Canc Res Grp, Med Oncol Dept, Philadelphia, PA USA

来源：

关键词：

D O I：

10.1016/j.annonc.2024.05.249

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

242MO

引用

页码：S104 / S104

页数：1